Form 8-K · Current report
3M 8-K, filed Oct 19, 2026
- Filed
- CIK
- 0000066740
- Accession no.
- 0000066740-26-000303
Summary
3M entered an expanded strategic commercial relationship with a wholly-owned subsidiary of Amazon.com on October 19, 2026, issuing a warrant to a separate Amazon subsidiary for up to 3,162,015 3M common shares at $164.89 per share over a seven-year period. 85% of those warrant shares vest as Amazon makes payments for optical connectivity and other data center products, with full vesting of that portion upon cumulative payments reaching $6 billion, while the remaining shares vest on event-based milestones.
Key points
- The warrant covers up to 3,162,015 shares of 3M common stock at $164.89 per share, exercisable over seven years.
- 85% of the warrant shares vest based on Amazon's payments for optical connectivity and other data center products, with full vesting at $6 billion in cumulative payments.
- The remaining warrant shares vest subject to event-based milestones.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 7.01Regulation FD Disclosure
From the filing
Item 7.01. Regulation FD Disclosure On October 19, 2026, 3M Company (“3M”) entered into an expanded strategic commercial relationship with a wholly-owned subsidiary of Amazon.com, Inc. (“Amazon”). 3M has issued a warrant (the “Warrant”) to a separate wholly-owned subsidiary of Amazon to purchase up to 3,162,015 shares (the “Warrant Shares”) of 3M common stock over a seven year period, at a purchase price per common share of $164.89. 85% of the Warrant Shares will vest subject to payments from Amazon for optical connectivity and other Data Center products, with full vesting once cumulative payments reach $6 billion, and the remaining Warrant Shares vesting subject to event-based milestones. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.